Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Ablbio

Biotech & Life Sciences · South Korea · Founded 2016 · IPO 2018 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Revenue
$67M
Latest reported FY

Investors

6 investors on Ablbio's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage
DSC Investment
Series B+ 5 investors entered at this stage
Korea Investment Partners
Hana Financial Investment
DS Asset Management
QUAD Investment Management
Alpenroute Asset Management

Global footprint

Where Ablbio has talent and traffic

Web traffic by country
23K monthly visits
across markets
🏳️ Korea81.7%
🏳️ Republic of10.9%
🇺🇸 United States5.7%
🇮🇳 India3%
🇨🇭 Switzerland0%
Top 5 markets shown

See Ablbio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo